Ethinamate

Synthesis of Ethinamate

Ethinamate is a sedative and hypnotic medication that was once commonly used for the short-term treatment of insomnia. It belongs to the class of carbamate derivatives and acts as a central nervous system depressant.

Pharmacology

Ethinamate works by enhancing the effects of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which leads to a calming effect on the central nervous system. This action helps to induce sleep and reduce anxiety in patients suffering from insomnia or other sleep disorders.

Medical Uses

Ethinamate was primarily prescribed for the short-term management of insomnia. Due to its potential for tolerance and dependence, it was generally recommended for use only when other treatments were ineffective or inappropriate.

Side Effects

Common side effects of ethinamate include drowsiness, dizziness, and headache. More serious side effects can include allergic reactions, respiratory depression, and confusion. Long-term use can lead to dependence and withdrawal symptoms upon discontinuation.

Synthesis

The synthesis of ethinamate involves the reaction of ethyl chloroformate with ethanolamine to form the corresponding carbamate. This process is depicted in the image to the right.

History

Ethinamate was first introduced in the 1950s and was widely used as a hypnotic agent. However, due to the development of newer and safer hypnotic drugs, its use has declined significantly.

Related Pages

• Sedative
• Hypnotic
• Carbamate
• Insomnia
• Gamma-aminobutyric acid